From Microbes to Medicine: Bacteriotherapy's Emerging Role in Cancer Treatment Strategies
- 3 December 2025
- journal article
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 22 (5) , 501-520
Abstract
Cancer, a prominent cause of death, continues to pose difficulties for traditional treatment methods due to the development of resistance in cancer cells. Despite the advances made in technology, the gradual and harmful growth of tumors sometimes results in death, which emphasizes the restrictions of current treatment methods. Bacteriotherapy, a treatment approach that uses bacteria, has become more important in cancer therapies as a reaction to these obstacles. This review examines the diverse use of bacteriotherapy in treating cancer, taking advantage of its inherent benefits compared to other approaches. Although some disease-causing bacteria have been linked to the development of tumors, a significant finding indicates that certain bacterial toxins and peptides possess exceptional abilities to combat cancer. Certain bacterial species, highly skilled at establishing themselves in solid tumors, have shown the capability to effectively regulate the abnormal growth of cancer cells, suppressing tumor advancement and leading to its eventual elimination from the body. Genetically edited bacteria, such as Streptococcus, E. coli, and Streptococcus pyogenes, have attracted attention due to their therapeutic effects in animal models and ongoing human trials. These genetically engineered bacterial strains have been designed to better colonize tumors. They are weakened and altered to be live and can reproduce within tumors. Significantly, genetically engineered bacterial species that are not harmful to humans are remarkable due to their strong attraction and specificity towards cancer cells, which greatly contributes to their impressive effectiveness in treating cancer.Keywords
This publication has 143 references indexed in Scilit:
- Bacterial l‐asparaginases for cancer therapy: Current knowledge and future perspectivesJournal of Cellular Physiology, 2019
- Therapeutic bacteria to combat cancer; current advances, challenges, and opportunitiesCancer Medicine, 2019
- Gene therapy clinical trials worldwide to 2017: An updateThe Journal of Gene Medicine, 2018
- Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein–protein interactions and cancer therapyProtein Science, 2017
- Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T‐cell malignanciesAmerican Journal of Hematology, 2017
- Induction of CD4+ and CD8+ anti‐tumor effector T cell responses by bacteria mediated tumor therapyInternational Journal of Cancer, 2015
- Immunomodulatory efficacy of nisin—a bacterial lantibiotic peptideJournal of Peptide Science, 2011
- Liver Cancer: Ephrina2 Promotes Tumorigenicity Through Rac1/Akt/Nf-κB Signaling PathwayHepatology, 2010
- Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitroBiotechnology and Bioengineering, 2006
- Combination of dietary factors in relation to breast‐cancer occurrenceInternational Journal of Cancer, 1991